BRIM Biotechnology, Inc. (TPE:6885)
Taiwan · Delayed Price · Currency is TWD 30.85
-0.65 (-2.06%)
Oct 20, 2026, 1:30 PM CST
BRIM Biotechnology Market Cap
BRIM Biotechnology has a market cap or net worth of 4.1 billion as of October 20, 2026. It is the 23,515th most valuable company in the world and the 1,199th biggest in Taiwan. Its market cap has decreased by 5.98% in one year.
Market Cap
4.10B
Enterprise Value
3.21B
Revenue
10.60M
Global Rank
Country Rank
#1,199 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 23, 2022, BRIM Biotechnology's market cap has increased from 1.77B to 4.10B, an increase of 132.45%. That is a compound annual growth rate of 21.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 4.10B | 3.58% |
| Dec 31, 2025 | 3.96B | -2.58% |
| Dec 31, 2024 | 4.07B | 17.34% |
| Dec 29, 2023 | 3.47B | -2.55% |
| Dec 30, 2022 | 3.56B | 101.45% |
| Jun 23, 2022 | 1.77B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mycenax Biotech | 4.73B |
| Medigen Biotechnology | 4.66B |
| Sunhawk Vision Biotech | 4.43B |
| UnicoCell Biomed | 4.41B |
| Sinew Pharma | 4.15B |
| Formosa Pharmaceuticals | 3.82B |
| Pharmosa Biopharm | 3.53B |
| SYN-TECH Chem. & Pharm. | 3.39B |